Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coffin

Showing results (421-430 of 477) with videos related to

Pageof 48
Sort By:
AIDS (London, England)|June 6, 2008
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cellsNancy M Archin, Joseph J Eron, Sarah Palmer, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA moleculeLina Josefsson, Martin S King, Barbro Makitalo, et al.
Antiviral Therapy|February 2, 2012
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in womenSarah Palmer, Valerie F Boltz, Jeremy Y Chow, et al.
Human Pathology|March 13, 2012
Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapyJustin M M Cates, Jennifer Black, Carmen C Wolfe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapineValerie F Boltz, Yu Zheng, Shahin Lockman, et al.
Journal of Clinical Microbiology|January 7, 2005
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysisSarah Palmer, Mary Kearney, Frank Maldarelli, et al.
Lancet (London, England)|August 16, 2005
Depletion of latent HIV-1 infection in vivo: a proof-of-concept studyGinger Lehrman, Ian B Hogue, Sarah Palmer, et al.
Plos Pathogens|April 7, 2021
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapyJohn M Coffin, Michael J Bale, Daria Wells, et al.
Advances in Virology|January 28, 2012
Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 InfectionJ Spindler, J Hackett, X Qiu, et al.
Pageof 48

Showing results (421-430 of 477) with videos related to

Sort By:
Pageof 48
AIDS (London, England)|June 6, 2008
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cellsNancy M Archin, Joseph J Eron, Sarah Palmer, et al.
Journal of Virological Methods|December 2, 2009
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer designValerie F Boltz, Frank Maldarelli, Neil Martinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA moleculeLina Josefsson, Martin S King, Barbro Makitalo, et al.
Antiviral Therapy|February 2, 2012
Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in womenSarah Palmer, Valerie F Boltz, Jeremy Y Chow, et al.
Human Pathology|March 13, 2012
Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapyJustin M M Cates, Jennifer Black, Carmen C Wolfe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapineValerie F Boltz, Yu Zheng, Shahin Lockman, et al.
Journal of Clinical Microbiology|January 7, 2005
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysisSarah Palmer, Mary Kearney, Frank Maldarelli, et al.
Lancet (London, England)|August 16, 2005
Depletion of latent HIV-1 infection in vivo: a proof-of-concept studyGinger Lehrman, Ian B Hogue, Sarah Palmer, et al.
Plos Pathogens|April 7, 2021
Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapyJohn M Coffin, Michael J Bale, Daria Wells, et al.
Advances in Virology|January 28, 2012
Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 InfectionJ Spindler, J Hackett, X Qiu, et al.
Pageof 48